Recent Updates
Recently added Catalysts
HAE Positive Sentiment

Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website Haemonetics Corporation (NYSE: HAE) announced that financial results for its second quarter fiscal year 2026, which ended September 27, 2025, are...

Key Takeaway: Haemonetics Corporation has released its financial results for the second quarter of fiscal year 2026, which ended on September 27, 2025. The results are available on their Investor Relations website. A conference call and webcast are scheduled for November 6, 2025, to discuss the results with investors and analysts.
Price reaction · baseline $50.72 (2025-11-05 close) · hit after-hours · clean, no other HAE news in the window
day 0 close
+32.3%
day 1
+34.8%
day 3 · peak
+41.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Haemonetics reported its financial results for Q2 FY 2026.
  • The company is hosting a conference call to discuss the results.
  • Innovative solutions are being highlighted for improving healthcare.

Full Press Release Details

Financial release and supplemental presentation accessible online
BOSTON , Nov. 6, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE ) announced that financial results for its second quarter fiscal year 2026, which ended September 27, 2025, are available on the Company's Investor Relations website at www.haemonetics.com .
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 6, 2025.
Conference Call and Webcast Information:
• Registration: Click here to register . Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended.
• Live webcast: Access here or through the Investor Relations section of the Haemonetics website.
A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on November 6, 2025 and will remain accessible for one year via the webcast link above.
Earnings Materials: Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
• Second Quarter Fiscal 2026 Earnings Release
• Second Quarter Fiscal 2026 Supplemental Earnings Presentation
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com .
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
David Trenk, Manager-Investor Relations
(781) 356-9763
(203) 733-4987
[email protected]
[email protected]
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
[email protected]

Frequently Asked Questions

When did Haemonetics announce its Q2 FY 2026 results?

Haemonetics announced its Q2 FY 2026 results on November 6, 2025.

Where can I find Haemonetics' financial results?

The financial results are available on Haemonetics' Investor Relations website.

What time is the conference call for Q2 results?

The conference call is scheduled for 8:00 a.m. ET on November 6, 2025.

Will there be a replay of the conference call?

Yes, a replay will be available starting at 11:00 a.m. ET on November 6, 2025.

Last updated: Nov 6, 2025